Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro

Pharmaceutical Research

Volumn 19, Issue 10, 2002, Pages 1480-1487

  Lutsiak, M E Christine ^a   Robinson, Deborah R ^a   Coester, Conrad ^a   Kwon, Glen S ^a   Samuel, John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antigen presenting cells; Dendritic cells; Phagocytosis; PLGA nanospheres

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NANOPARTICLE; PHOSPHORYL LIPID A; POLYGLACTIN;

ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; EVAPORATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MACROPHAGE; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

CELLS, CULTURED; DENDRITIC CELLS; HUMANS; LACTIC ACID; MACROPHAGES; MICROSPHERES; NANOTECHNOLOGY; PHAGOCYTOSIS; POLYGLYCOLIC ACID; POLYMERS;

EID: 0036805438     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020452531828     Document Type: Article

References (30)

1. J. Banchereau and R. M. Steinman. Dendritic cells and the control of immunity. Nature 392:245-252 (1998).
2. M. Croft, D. Duncan, and S. Swain. Response of naive antigen-specific CD4+ T cells in vitro: Characteristics and antigen-presenting cell requirements. J. Exp. Med. 176:1431-1437 (1992).
3. F. Fagnoni, M. Takamizawa, W. Godfrey, A. Rivas, M. Azuma, K. Okumura, and E. Engleman. Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells. Immunology 85: 467-474 (1995).
4. J. Guery and L. Adorini. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J. Immunol. 154:536-544 (1995).
5. R. Thomas, L. Davis, and P. Lipsky. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J. Immunol. 151:6840-6852 (1993).
6. S. Macatonia, N. Hosken, M. Litton, P. Vieira, C. Hsieh, J. Culpepper, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154:5071-5079 (1995).
7. C. Heufler, F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R. Steinman, N. Romani, and G. Schuler. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 26:659-668 (1996).
8. L. Fong and E. Engleman. Dendritic cells in Cancer Immunotherapy. Annu. Rev. Immunol. 18:245-273 (2000).
9. J. T. Timmerman and R. Levy. Dendritic cell vaccines for cancer immunotherapy. Annu. Rev. Med. 50:507-529 (1999).
10. M. D. Witmer-Pack, M. T. Crowley, K. Inaba, and R. M. Steinman. Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ. J. Cell Sci. 105:965-973 (1993).
11. C. Reise Sousa and J. M. Austyn. Phagocytosis of antigens by Langerhans cells. In Dendritic Cells in Fundamental and Clinical Immunology, 1993, pp. 199-204.
12. L. Filgueira, F. O. Nestle, M. Rittig, H. I. Joller, and P. Groscurth. Human dendritic cells phagocytose and process Borrelia burgdorferi. J. Immunol. 157:2998-3005 (1996).
13. K. Inaba, M. Inaba, M. Naito, and R. M. Steinman. Dendritic cell progenitors phagocytose particulates, including Bacillus calmetteguerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479-488 (1993).
14. J. Ma, D. Luo, G. S. Kwon, J. Samuel, A. A. Noujaim, and R. Madiyalakan. Use of encapsulated single chain antibodies for induction of anti-idiotypic humoral and cellular immune responses. J. Pharm. Sci. 87:1375-1378 (1998).
15. J. Ma, J. Samuel, G. S. Kwon, A. A. Noujaim, and R. Madiyalakan. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres. Cancer Immunol, Immunother. 47:13-20 (1998).
16. K. D. Newman, J. Samuel, and G. Kwon. Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. J. Control. Release 54:49-59 (1998).
17. K. D. Newman, D. L. Sosnowski, G. S. Kwon, and J. Samuel. Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses. J. Pharm. Sci. 87:1421-1427 (1998).
18. D. Wang, D. R. Robinson, G. S. Kwon, and J. Samuel. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-coglycolic acid) microspheres as a novel approach for immunogene delivery. J. Control. Release 57:9-18 (1999).
19. C. D. Partidos, P. Vohra, C. Anagnostopoulou, D. H. Jones, G. H. Farrar, and M. W. Steward. Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes. Mol. Immunol. 33:485-491 (1996).
20. C. D. Partidos, P. Vohra, D. H. Jones, G. H. Farrar, and M. W. Steward. Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles. J. Immunol. Methods 195:135-138 (1996).
21. D. F. Nixon, C. Hioe, P. D. Chen, Z. Bian, P. Kuebler, M. L. Li, H. Qiu, X. M. Li, M. Singh, J. Richardson, P. McGee, T. Zamb, W. Koff, C. Y. Wang, and D. O'Hagan. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine 14:1523-1530 (1996).
22. G. D. Moore and H. B. Croxatto. Synthetic microspheres transferred to the rat oviduct on day I of pregnancy mimic the transport of native ova. J. Reprod. Fertil. 82:735-742 (1988).
23. F. Sallusto and A. Lanzavecchia. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118 (1994).
24. F. Chapuis, M. Rosenzwajg, M. Yagello, M. Ekman, P. Biberfeld, and J. C. Gluckman. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27:431-441 (1997).
25. S. M. Kiertscher and M. D. Roth. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J. Leukoc. Biol. 59:208-218 (1996).
26. Y. Ogawa, M. Tamamoto, H. Okada, T. Yashiki, and T. Shimamoto. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem. Pharm. Bull. 36:1095-1103 (1988).
27. A. T. Davis, R. Estensen, and P. G. Quie. Cytochalasin B. 3. Inhibition of human polymorphonuclear leukocyte phagocytosis. Proc. Exp. Biol. Med. 137:161-164 (1971).
28. H. Xu, M. Kramer, H. P. Spengler, and J. H. Peters. Dendritic cells differentiated from human monocytes through a combination of IL-4, GM-CSF and IFN-gamma exhibit phenotype and function of blood dendritic cells. Adv. Exp. Med. Biol. 378:75-78 (1995).
29. C. Schutt. CD14. Int. J. Biochem. Cell Biol. 31:545-549 (1999).
30. A. Aderem and D. Underhill. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593-623 (1999).